Purpose: Our purposes are to compare the accuracy of RaySearch's analytical pencil beam (APB) and Monte Carlo (MC) algorithms for clinical proton therapy and to present clinical validation data using a novel animal tissue lung phantom.
| INTRODUCTION
Lung and bronchus is now the most common cancer site in 16 states and second overall in the United States, with only 12% fewer estimated cases than female breast. 1 Given the principle to keep radiation exposure as low as reasonably achievable, 2 combined with the benefits of hypo fractionated proton therapy, [3] [4] [5] [6] the need to increase the accuracy of proton radiotherapy to thoracic sites has thus become imperative. Most proton clinics are currently using commercially available analytical pencil beam (APB) algorithms. [7] [8] [9] These APB algorithms are typically designed to be computationally efficient, but inherently include simplifications of the transport problem as compared to, for example, Monte Carlo (MC)-based algorithms. Consequently, the APB algorithm sometimes suffers loss of accuracy in areas of inhomogeneity, such as in lung, where even small algorithmic deficiencies can result in significant shifts of dose distributions. 10 It has been shown by Taylor et al. that the APB algorithm is "doing a poor job" of predicting dose in lung tumors, with over-predictions up to 46% in the PTV. 11 In the case of lateral heterogeneities, MC dose calculation algorithms are superior in calculating accurate dose distributions. [12] [13] [14] MC is viewed as the gold standard for dose calculation for most radiation transport calculations, but traditional MC algorithms such as MCNPX 15, 16 and Gean-t4 16 are too slow to keep up with clinical workflow. To combat this problem, Fast Monte Carlo (FMC) dose engines have been developed for clinical use. 10, 17 A study by Sorriaux et al. compared both MC and FMC dose engines with APB in clinical situations of heterogeneity. 18 They found that FMC corresponded well with data measured in an inhomogeneous phantom made of water surrounding a long insert of bone tissue substitute, whereas more than half of the APB dose distributions failed gamma-index analysis. 16 We explain in another study how the RaySearch APB and MC algorithms work. 19 When the MC dose engine became available in RayStation 6 (RaySearch Laboratories AB, Stockholm, Sweden), we proposed to validate it using animal tissue and realistic phantoms, because the use of animal tissue phantoms in dose validation has seen useful results, 20,21 similar to using wood or cork to approximate lung tissue. 22, 23 Previously, we studied these algorithms applied to animal neck phantoms and a water-based breast phantom. 19 In this study, we focused on validating the MC algorithm for a more complex lung phantom made of a composite of lamb ribs, ground lamb meat and cork. We demonstrate that we can measure dose inside a realistic lung tumor phantom for a target not adjacent to the chest wall, that is, a tumor surrounded by lower density lung tissue. We then compared the measured data with doses calculated using the RaySearch APB and MC algorithms. We searched articles available to the public from multiple journals concerning lung phantoms.
Although a number of phantoms have been tested, including solid water, 24, 25 cork and solid water, [26] [27] [28] [29] balsa wood and solid water, 30 balsa wood and cork, 11 cork and plastic, 31, 32 cork and acrylic, 33, 34 polystyrene and cork, 35 bolus and sponge, 36 foam, 37, 38 and even wood, 39, 40 it appears that we are the first to report open-access on the use of a cork-and-animal-tissue lung tumor phantom.
| METHODS

2.A | Dose validation phantom
The lung phantom is shown in Fig. 1 . The lung phantom was composed of a rack of lamb containing real rib bones, intercostal muscle, and fat. To simulate lung tissue beneath the lamb rack, we placed 5.0 ± 0.5 mm thick layers of Quartet cork (ACCO Brands, Lake Zurich, Illinois; SKU 48112Q) obtained from a hardware store. The cork slabs and the rack of lamb were pinned together using wooden toothpicks to allow for splitting and re-assembling the phantom accurately enabling measurements "inside" the phantom.
An approximately spherical hole 40 ± 5 mm in diameter was cut into the cork after five cork slabs. This placed the proximal edge of the cavity at a physical depth of approximately 2.5 cm beyond the chest wall. The cavity was filled with 70% lean ground lamb meat to simulate a solid lung tumor with an effective mass density slightly less than muscle. We used plastic Glad® Cling Wrap to divide this tumor in two halves so that planar dose measurements could be made within and distal to the tumor. The physical thickness of the simulated chest wall anterior to the tumor varied between 1.5 and 1.8 cm. The gross tumor volume (GTV), represented by the cavity filled with ground lamb meat and drawn on the planning CT scan, had a volume of 26.3 cm 3 which is representative of solid lung tumors our clinic treats with protons. Smaller lung tumors are typically treated with x rays using SBRT techniques. The average HU of the GTV was 46 ± 21. The entire phantom was constructed with the rack of lamb frozen to measure the geometry, cut the cork slabs, and carve the cavity for the tumor in the cork. On the day of the experiment, the rack of lamb and ground lamb meat were thawed, and the latter was inserted into the cavity. In a single day, the phantom was scanned, treatment planning was performed, the beams were delivered to the phantom, and the doses were measured.
2.B | Treatment planning
The lung phantom was scanned on a Siemens Somatom Definition AS CT scanner (Siemens Medical Solutions USA, Inc., Malvern, PA, USA) using a 50 cm Field of View (FOV) obtaining 512 × 512 pixel axial images (0.98 × 0.98 mm 2 pixel size) reconstructed with a 4 mm slice distance between images (131 axial images). The phantom was marked with a pen and BBs to ensure the alignment could be accurately reproduced. Using RayStation, the GTV was delineated and expanded to a CTV using a 5 mm uniform margin. The CTV was used as the target in the optimization of the plans. We developed two pencil-beam scanning (PBS) plans as shown in Fig. 2 . The first plan used a single anterior field and a second plan used two anterior oblique fields that were optimized using the single field uniform dose (SFUD) technique i.e. each field delivered a uniform dose to the CTV. For both plans, the isocenter was centered within the tumor. A 7.5 cm WET Lucite range shifter with physical thickness of 6.7 cm was used, and the airgap, here defined as the smallest distance between the range shifter and the phantom surface, -was kept as small as possible. An air gap of 1.6 cm was used for the single-field lung plan. Beam 1 of the two-field plan also used a 1.6 cm airgap while beam 2 used a 2 cm airgap. The two plans were optimized to deliver a uniform dose of 2 Gy(RBE) in one fraction to the target.
The plans were optimized using the APB algorithm in RayStation (RS) 6.0 using a 1 × 1 × 1 mm 3 calculation grid. The doses of the APB plans were then recomputed using the RS 6.0 MC dose engine to a statistical uncertainty in the high dose region of 0.5% per beam.
The RS6.0 APB doses were subsequently recomputed using RS 6.2, due to an updated handling of the range shifter in the APB algorithm that became available in that version.
One of the known deficiencies of the APB algorithm is calculating the dose when a range shifter is used. 41 During commissioning of the APB RS 6.2 and the MC RS 6.0 algorithms for clinical use, we measured the CAX depth dose for a typical breast treatment beam with a Markus parallel plate ionization chamber in a water tank for a zerodegree gantry angle. We used different air gaps between the range shifter and the water surface. The deficiency in APB calculations was confirmed as can be seen in Fig. 3 . It is clear from the data in Fig. 3 that the MC algorithm reduces the uncertainty with airgap to a clinically insignificant level. To minimize this airgap effect of the APB dose engine, we kept the airgaps as small as possible in this study.
The MatriXX PT detector (Ion Beam Applications S.A., Louvainla-Neuve, Belgium) used to measure the dose in the lung phantom has a 6.2 mm water-equivalent buildup region proximal to the plane of measurement. This build-up region was included in our treatment plans by drawing two 6.2 × 80 mm 2 rectangular slab contours on each axial CT slice within the treatment volume. The top edge of each contour was aligned with the mid and distal measurement planes, respectively, that is, the positions in the phantom where the proximal surface of the MatriXX PT detector was located during the respective measurements. We simulated the insertion of the MatriXX PT detector by overriding the material in the 6.2 mm rectangular slab contours, referred to hereafter as "the MatriXX PT slab", to water. The dose was recalculated for each of the measurement conditions at the mid and distal planes. When the mid plane dose was calculated, the MatriXX PT slab in the middle of the tumor was set to water, while the material for the distal MatriXX PT slab was the MD and SPR for lung are almost equal. 43 Our measured SPR value for cork was 0.296 ± 0.02, as mentioned earlier.
The conversion from HU to stopping power in RayStation is only expected to be correct for phantoms with human like tissue. For the present phantom the mass stopping power for cork is not expected to be the same as for lung tissue. To study the effect of the HU-to-MD curve a series of curves were created where the mass density of the curves was uniformly scaled by 6% up to 8% in steps of 2%.
The doses of both plans were then recomputed for each of the F I G . 4. Measurement depths illustrated for verifying the calculated dose for the Anterior 1 field plan. The MatriXX PT rectangular slab contours for the mid and the distal measurement planes are illustrated with the teal and violet contours respectively.
The dark blue rectangular contour shows the volume used to calculate the HU histogram shown in Fig. 5 .
scaled curves, and 2%/2 mm gamma analysis was conducted for the two measured planes of the two plans. Guided by these results, we recalculated all the beams with a modified HU-to-MD curve where the mass density was increased by 5% over the cork region only, that is, 1% more than when the entire curve was scaled, as shown in Fig. 5 (zoomed box) . The 5% shift is within the uncertainty of 7% in the measured stopping power for cork, as detailed above. Because our work using animal neck phantoms and a water-based breast phantom revealed that the HU-to-MD curve in the soft tissue, water and bone region is adequately accurate, we decided to leave that portion of the HU-to-MD curve unchanged. 19 
2.C | Measurements
All measurements were taken in an IBA Proteus Plus Gantry treatment room (Ion Beam Applications S.A., Louvain-la-Neuve, Belgium).
The phantoms were aligned using external markers and the Veri-Suite IGRT system (MedCom, Darmstadt, Germany), employing orthogonal x rays as performed clinically. Dose distribution measurements were taken using the MatriXX PT in the mid and distal planes only, corresponding to depths of 8.01 cm and 9.67 cm, relative to the proximal plane of the calculation grid (see Fig. 4 ). For the distal plane measurement at a depth of 9.67 cm, the phantom was split at the distal plane of the tumor, and only the upper section was accurately placed on the MatrriXX PT detector using the orthogonal x rays in the treatment room. The same process was repeated for the mid plane measurement at a depth of 8.01 cm, splitting the phantom at the mid plane of the tumor. In each case, the table height was adjusted to place the phantom isocenter at the beam isocenter. The toothpicks that were used to assemble the phantom ensured that the phantom was split and re-assembled without significant shifts between the layers, maintaining the geometry of the phantom.
2.D | Data analysis
The MatriXX PT detector is composed of 1024 small parallel plate ionization chambers spaced 7.62 mm apart in a rectangular grid pattern. Each ion chamber has a collecting diameter of 5 mm, but were treated as dose points in the subsequent analysis. Three-dimensional gamma analyses were performed using tools in the RaySearch Laboratories dose engine validation test suite. The gamma evaluation algorithm of this RaySearch internal software package is the same as that used in the patient specific QA system Compass© from IBA Dosimetry and RaySearch Laboratories. The measured lateral dose maps were compared to calculated APB and MC 3D dose cubes using gamma analysis parameters of 2%/2 mm, 3%/3 mm, and 5%/ 3 mm. 44 The measured dose distributions were used as the reference dose distributions for the gamma index analyses. The gamma analysis was performed using absolute doses and global gamma was considered. The normalization dose was taken as the maximum dose of the computed doses. 44 Furthermore, a 10% gamma threshold was used, that is, only doses above 10% of the max dose were included in the analyses. Prior to the gamma analysis, the measured and calculated dose planes were registered to each other to eliminate unavoidable setup errors due to the inherent resolution of the image guidance system used to align the phantom in the beam.
Using the gamma index as the only parameter to evaluate a dose calculation algorithm against measured data is perhaps not the best method, particularly for smaller fields. | 131
| RESULTS
The result of the 2%/2 mm gamma passing rates using the uniformly scaled HU-to-MD curves is depicted in Fig. 6 . A maximum in passing rate is revealed for a uniform scaling somewhere between 0% and 6%, with the best average improvement for all plans and depths obtained at 4%. Three of the four cases follow very similar curves, while the Lung 1 Field plan at mid depth seems shifted about 2% with respect to the others. The reason for this slightly different behavior is unclear, but some systematic deviation in the setup of this measurement could be an explanation. We interpret the systematic improved passing rate for a uniform scaling of the HU-to-MD curve as mainly being caused by the difference in interpreted and the real stopping power of cork. This assumption is supported by the results in the previous study where only animal tissues were used together with the original HU-to-MD curve. 19 As mentioned earlier we recalculated all the beams with a modified HU-to-MD curve where the mass density was increased by 5% over the cork region only. The results for the 3D gamma analyses for the calculated and measured distributions using the original and the modified HU-to-MD curves for both the APB and MC algorithms are tabulated in Table 1 .
The Fig. 8 . The calculated distributions for the two-field plan are compared in Fig. 9 . The transverse dose profile (in-plane x direction and cross-plane y direction) comparisons for the measured and calculated doses in the distal plane of the two-field lung plan at a depth of 9.65 cm are shown in Fig. 10 . There is an overestimation of dose from the APB algorithm, whereas MC predicts the measured values much more closely.
| DISCUSSION
4.A | Interpretation of results
There is a significant overestimation of the dose in the distal part of the tumor using the APB algorithm. It deviates from the MC algorithm when the beam enters the denser-than-lung tumor volume. As finite slabs. [7] [8] [9] 24 The RayStation APB algorithm utilizes a sub-spot approach where each spot is discretized into 19 sub spots to alleviate this problem. Additionally, the transport of secondary protons created in the range shifter is not properly handled in the APB algorithm, leading to an overestimation of dose. As illustrated in Fig. 3 , this effect increases with increasing airgap and is more pronounced in the proximal region of the patient. We hypothesize that the error introduced by the infinite-slab-approximation in the APB algorithm was the cause of the increasing discrepancy between APB and MC as the beam traversed the lung tumor. Data comparisons revealed that the measured and MC calculated doses can differ by as much as 30% in distal part of the tumor. Some of these discrepancies are illustrated by the dose profiles and the dose difference maps, shown in 7-10. The dose distal to the tumor differed more than dose within the tumor, and the single-field plan had greater discrepancy than the two-field plan. These line profiles illustrate the marked superiority of MC over APB. We emphasize that the deficiencies of the analytical F I G . 6. The 3D 2%/2 mm gamma pass rates for the 1 Field and 2 Field MC calculated lung plans at the expected depths as a function of the percentage correction applied to the entire HU to Mass density curve in RayStation.
dose engine presented in this paper only addresses the APB dose engine implemented in RayStation. However, it appears likely that other implementations of pencil-beam/infinite slab-based algorithms for protons will exhibit similar problems.
Our phantom was designed to have the tumor suspended inside the lung tissue instead of being adjacent to the chest wall. Making a phantom with the tumor adjacent to the chest wall will make it harder to measure dose inside the tumor due to the curvature of the chest T A B L E 1 3D Gamma passing rates (%) comparing RayStation APB and MC doses to the MatriXX PT measurements at two depth for the two lung phantom plans using the original CT to Mass Density calibration curve as well as the calibration curve with the Mass Density scaled by 5% in the cork region.
Plan Algorithm
Physical Plane There is no reason to believe that a CT scan and a CT-to-MD curve calibrated for human-like tissues would reveal the correct stopping power for cork, which allowed us to make a 5% correction in the cork mass density to obtain better results. The 5% correction is within the uncertainty limits of the measured RSP value for cork listed above. The main purpose of this study was to test the difference between the MC and APB algorithms in a highly non-homogeneous region, such as a tumor suspended completely within the lung. The fact that we achieved extremely good depth agreements between the measured and calculated dose distributions is encouraging from a beam range accuracy perspective. However, the main finding of this work is evident in the excellent agreement in the line dose profiles between the measured and MC-calculated distributions distal to the tumor as illustrated in Fig. 8 and Fig. 10 . This was not the case for the APB calculated distributions.
4.B | Clinical impact of our phantom
The ground meat simulating the tumor is a reasonable representation of a real solid tumor and is readily separable to enable dose measurement inside the tumor. Lung tumors are mostly less dense than soft tissue, which was achieved by using 70% lean ground meat as the tumor. We reviewed the HUs of solid lung tumors of two patients we treated and found that the average HU for the GTVs drawn for these patients was 35 ± 26 which compared well with our simulated lung tumor having a mean HU value of 46 + 21. The frequency distributions for two real lung tumors and for the simulated lung tumor are shown in Fig. 11 . The simplicity of this model may be contrasted with an elaborate lung phantom involving a water-filled casing with porcine lung, 45 a commercial synthetic torso, 46, 47 or a commercial pig organ phantom. 48 
4.C | RaySearch warnings
RaySearch informs the user that the pencil beam scanning dose engine uses the infinite slab approximation thereby increasing error as a function of lateral inhomogeneity. 50 We demonstrate this behavior, as shown in 7-10. They strongly recommend using the Monte Carlo dose engine for final dose computation. We concur based on the results shown in this report.
| CONCLUSIONS
We have created a novel phantom simulating a lung cancer tumor, representative of the typical size and location of patient cases often treated in our clinic. This phantom enabled us to determine the errors resulting from using an analytical pencil beam algorithm for lung targets. We were able to demonstrate the superiority of the Monte Carlo dose calculation algorithm for lung targets. This work also demonstrated how the infinite slab approximation used in the APB algorithm fails when a distinct lateral inhomogeneity is encountered at the distal end of an otherwise fairly uniform medium. The case represented in this phantom is, in our estimation, one of the worst cases that one would encounter in the lung: namely, the tumor is not adjacent to the rib cage but rather suspended in the lung. This represents many centrally located lung targets. In addition, the plans created for this study were not created using robust optimization, something that would have decreased the sensitivity to dose calculation error. Therefore, based on this work and supported by many other authors referenced herein, we recommend that APB algorithms should not be used for any lung targets, and that a Monte Carlo based algorithm should be used as the dose engine for plan optimization and final dose calculation.
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